• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂质体作为抗生素的递送系统。

Liposomes as delivery systems for antibiotics.

机构信息

Institute of Genetics and Microbiology, University of Wroclaw, Przybyszewskiego 63/77, 51-148 Wroclaw, Poland.

出版信息

Int J Pharm. 2010 Mar 15;387(1-2):187-98. doi: 10.1016/j.ijpharm.2009.11.033. Epub 2009 Dec 5.

DOI:10.1016/j.ijpharm.2009.11.033
PMID:19969054
Abstract

Liposomes are currently in common use as universal drug carriers in the cosmetic and pharmaceutical industries. The manipulation of different physicochemical properties of liposomes enables the design of particular carriers with the desired pharmacokinetic and pharmacodynamic properties. Most studies regarding liposomal antibiotics deal with aminoglycosides, quinolones, polypeptides, and betalactames. Some of the studies focused on improving pharmacokinetics and reducing toxicity, while others involved enhancing antibacterial activity. In an era of an avalanche of increasing bacterial resistance and severe problems in treating bacterial infections, the application of liposomal antibiotic carriers could be useful, but the high cost of liposome preparation and treatment should also be considered.

摘要

脂质体目前在化妆品和制药行业中被普遍用作通用药物载体。通过操纵脂质体的不同物理化学性质,可以设计出具有所需药代动力学和药效学特性的特定载体。大多数关于脂质体抗生素的研究都涉及氨基糖苷类、喹诺酮类、多肽和β-内酰胺类。一些研究侧重于改善药代动力学和降低毒性,而另一些则涉及增强抗菌活性。在细菌耐药性不断增加和细菌感染治疗问题严重的时代,脂质体抗生素载体的应用可能是有用的,但也应考虑到脂质体制备和治疗的高成本。

相似文献

1
Liposomes as delivery systems for antibiotics.脂质体作为抗生素的递送系统。
Int J Pharm. 2010 Mar 15;387(1-2):187-98. doi: 10.1016/j.ijpharm.2009.11.033. Epub 2009 Dec 5.
2
Liposomal drug delivery systems--clinical applications.脂质体药物递送系统——临床应用
Acta Pharm. 2005 Mar;55(1):1-25.
3
[Progress of liposomes as antibiotic carriers].[脂质体作为抗生素载体的研究进展]
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2012 Nov;26(11):1387-90.
4
Liposomes and lipid carriers in the treatment of microbial infections.脂质体和脂质载体在微生物感染治疗中的应用。
Scand J Infect Dis Suppl. 1990;74:34-41.
5
[Ectericide as a dispersion medium for the preparation of prospective clinical liposomal drug forms].[用于制备前瞻性临床脂质体药物剂型的杀菌剂作为分散介质]
Vestn Akad Med Nauk SSSR. 1990(6):40-4.
6
Liposomes as carriers for antibiotics.脂质体作为抗生素的载体
Targeted Diagn Ther. 1990;3:337-54.
7
Antibacterial activity of liposomal gentamicin against Pseudomonas aeruginosa: a time-kill study.脂质体庆大霉素对铜绿假单胞菌的抗菌活性:一项时间杀菌研究。
Int J Antimicrob Agents. 2006 Mar;27(3):247-52. doi: 10.1016/j.ijantimicag.2005.10.021. Epub 2006 Feb 10.
8
[Development of antituberculous drugs: current status and future prospects].[抗结核药物的研发:现状与未来前景]
Kekkaku. 2006 Dec;81(12):753-74.
9
Antimicrobial effectiveness of liposomal polymyxin B against resistant Gram-negative bacterial strains.脂质体多粘菌素B对耐药革兰氏阴性菌菌株的抗菌效果。
Int J Pharm. 2008 May 1;355(1-2):293-8. doi: 10.1016/j.ijpharm.2007.11.035. Epub 2007 Nov 24.
10
Delivery systems to increase the selectivity of antibiotics in phagocytic cells.提高抗生素在吞噬细胞中选择性的递送系统。
J Control Release. 2008 Feb 11;125(3):210-27. doi: 10.1016/j.jconrel.2007.10.027. Epub 2007 Nov 12.

引用本文的文献

1
Nanomaterials: A Prospective Strategy for Biofilm-Forming Treatment.纳米材料:一种用于生物膜形成治疗的前瞻性策略。
Int J Nanomedicine. 2025 Apr 23;20:5209-5229. doi: 10.2147/IJN.S512066. eCollection 2025.
2
Ionizable Lipid Containing Nanocarriers for Antimicrobial Agent Delivery.用于抗菌剂递送的含可电离脂质纳米载体
Small Sci. 2024 Aug 13;4(10):2400145. doi: 10.1002/smsc.202400145. eCollection 2024 Oct.
3
Effectiveness of a Novel Liposomal Methylglyoxal-Tobramycin Formulation in Reducing Biofilm Formation and Bacterial Adhesion.
一种新型脂质体甲基乙二醛-妥布霉素制剂在减少生物膜形成和细菌黏附中的有效性。
Antibiotics (Basel). 2024 Dec 24;14(1):3. doi: 10.3390/antibiotics14010003.
4
Mechanism of antibacterial resistance, strategies and next-generation antimicrobials to contain antimicrobial resistance: a review.抗菌耐药机制、遏制抗菌耐药的策略及下一代抗菌药物:综述
Front Pharmacol. 2024 Aug 16;15:1444781. doi: 10.3389/fphar.2024.1444781. eCollection 2024.
5
Advances in Intrathecal Nanoparticle Delivery: Targeting the Blood-Cerebrospinal Fluid Barrier for Enhanced CNS Drug Delivery.鞘内纳米颗粒递送的进展:靶向血脑脊髓液屏障以增强中枢神经系统药物递送
Pharmaceuticals (Basel). 2024 Aug 15;17(8):1070. doi: 10.3390/ph17081070.
6
The protagonist of contemporary and emerging nanotechnology-based theranostics and therapeutic approaches in reshaping intensive care unit.基于当代和新兴纳米技术的治疗学和治疗方法的主角正在重塑重症监护病房。
Saudi Med J. 2024 Aug;45(8):759-770. doi: 10.15537/smj.2024.45.8.20240069.
7
Comparative efficacy of difloxacin and nano-emulsion difloxacin as antibacterial agents against in chickenss.比较二氟沙星和纳米乳二氟沙星作为抗菌剂对鸡 的抗菌效果。
Open Vet J. 2024 Jan;14(1):449-458. doi: 10.5455/OVJ.2024.v14.i1.41. Epub 2023 Jul 31.
8
Toxin-triggered liposomes for the controlled release of antibiotics to treat infections associated with the gram-negative bacterium, Aggregatibacter actinomycetemcomitans.毒素触发的脂质体用于控制抗生素的释放,以治疗与革兰氏阴性菌伴放线放线杆菌相关的感染。
Colloids Surf B Biointerfaces. 2024 Jun;238:113870. doi: 10.1016/j.colsurfb.2024.113870. Epub 2024 Mar 21.
9
Evaluation of the antifungal properties of nanoliposomes containing rhinacanthin-C isolated from the leaves of Rhinacanthus nasutus.评价从药用植物尖叶山矾叶中分离得到的藏红花酸-C 纳米脂质体的抗真菌性能。
World J Microbiol Biotechnol. 2024 Mar 9;40(4):129. doi: 10.1007/s11274-024-03916-0.
10
Liposomes: An Emerging Strategy for the Effective Treatment of Rheumatoid Arthritis.脂质体:一种有效治疗类风湿关节炎的新兴策略。
Curr Rheumatol Rev. 2025;21(2):123-143. doi: 10.2174/0115733971284274240215064826.